FDA
- Status: approved
🇺🇸 placebo sitagliptin in United States
placebo sitagliptin (placebo sitagliptin) regulatory status in United States.
Marketing authorisation
placebo sitagliptin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Diabetes approved in United States
Frequently asked questions
Is placebo sitagliptin approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for placebo sitagliptin in United States?
GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.